Literature DB >> 10867795

Expression of MyoD and myogenin in dystrophic mice, mdx and dy, during regeneration.

Y Jin1, N Murakami, Y Saito, Y Goto, K Koishi, I Nonaka.   

Abstract

Expression of two myogenic regulatory factors, MyoD and myogenin, was studied in regenerating muscles of dystrophic mice and compared to a chemically induced regeneration process. First, the distribution of the two proteins was determined immunohistochemically at various time points after single administrations of a local anaesthetic, bupivacaine hydrochloride, which causes myonecrosis followed by regeneration. Detectable levels of MyoD appeared at 18 h and the expression reached their maximum levels at 48 h after the injection, which coincide with the stage when satellite cells are activated and start to proliferate. Myogenin became detectable in 24 h and its expression reached its highest level at 72 h after injection when newly formed myotubes appeared. The two genes were also expressed in the dystrophic muscles from dy and mdx mice which exhibit dystrophic pathological features but are associated with different phenotypes. In mdx mice the two genes were expressed at reasonably high levels in parallel with the active regenerating process, whereas in dy mice MyoD and myogenin expressions decreased as fibrosis progressed. However, MyoD was relatively more strongly expressed in the larger mature myotubes of dy mice than in those of mdx mice, suggesting prolonged regenerative activity. In dy and mdx mice, MyoD and myogenin were expressed in different quantities, indicating that these animals have distinct regenerating activities. Our findings confirm that expression of both MyoD and myogenin genes is necessary in the regenerative process for the proliferation of satellite cells (myoblasts) and for the development of early regenerating fibers (myotubes) even in dystrophic muscles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867795     DOI: 10.1007/s004010051172

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  14 in total

Review 1.  Cellular dynamics in the muscle satellite cell niche.

Authors:  C Florian Bentzinger; Yu Xin Wang; Nicolas A Dumont; Michael A Rudnicki
Journal:  EMBO Rep       Date:  2013-11-15       Impact factor: 8.807

2.  IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation.

Authors:  S Armando Villalta; Bo Deng; Chiara Rinaldi; Michelle Wehling-Henricks; James G Tidball
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.422

3.  Prednisolone treatment does not interfere with 2'-O-methyl phosphorothioate antisense-mediated exon skipping in Duchenne muscular dystrophy.

Authors:  Ingrid E C Verhaart; Hans Heemskerk; Tatyana G Karnaoukh; Ingrid G M Kolfschoten; Anne Vroon; Gert-Jan B van Ommen; Judith C T van Deutekom; Annemieke Aartsma-Rus
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

4.  Myogenic differentiation factor 1 and myogenin expression not elevated in regenerated masticatory muscles of dystrophic (mdx) mice.

Authors:  Alexander Spassov; Tomasz Gredes; Christian Lehmann; Tomasz Gedrange; Silke Lucke; Dragan Pavlovic; Christiane Kunert-Keil
Journal:  J Orofac Orthop       Date:  2011-11-30       Impact factor: 1.938

5.  BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model.

Authors:  SongTing Shi; Willem M H Hoogaars; David J J de Gorter; Sandra H van Heiningen; Herbert Y Lin; Charles C Hong; Dwi U Kemaladewi; Annemieke Aartsma-Rus; Peter ten Dijke; Peter A C 't Hoen
Journal:  Neurobiol Dis       Date:  2010-10-16       Impact factor: 5.996

6.  Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states.

Authors:  Ronald D Cohn; Christel van Erp; Jennifer P Habashi; Arshia A Soleimani; Erin C Klein; Matthew T Lisi; Matthew Gamradt; Colette M ap Rhys; Tammy M Holm; Bart L Loeys; Francesco Ramirez; Daniel P Judge; Christopher W Ward; Harry C Dietz
Journal:  Nat Med       Date:  2007-01-21       Impact factor: 53.440

7.  Myogenin regulates exercise capacity but is dispensable for skeletal muscle regeneration in adult mdx mice.

Authors:  Eric Meadows; Jesse M Flynn; William H Klein
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

8.  Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy.

Authors:  Laurin M Hanft; Daniel J Bogan; Ulrike Mayer; Stephen J Kaufman; Joe N Kornegay; James M Ervasti
Journal:  Neuromuscul Disord       Date:  2007-05-01       Impact factor: 4.296

9.  Conditional TGF-β1 treatment increases stem cell-like cell population in myoblasts.

Authors:  Xiaodong Mu; Yong Li
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

10.  Impaired skeletal muscle regeneration in the absence of fibrosis during hibernation in 13-lined ground squirrels.

Authors:  Eva Andres-Mateos; Rebeca Mejias; Arshia Soleimani; Brian M Lin; Tyesha N Burks; Ruth Marx; Benjamin Lin; Richard C Zellars; Yonggang Zhang; David L Huso; Tom G Marr; Leslie A Leinwand; Dana K Merriman; Ronald D Cohn
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.